Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Haemonetics Corporation (HAE)

Surgical & Medical Instruments & Apparatus

https://www.haemonetics.com

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

125 SUMMER STREET
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/09/1991

Market Cap

3,817,344,643

Shares Outstanding

50,740,000

Weighted SO

50,742,477

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

MMSI --.--%

ANGO --.--%

ATR --.--%

NVST --.--%

HOLX --.--%

ICUI --.--%

COO --.--%

TFX --.--%

WST --.--%

Beta

0.2910

Last Div

0.0000

Range

70.74-97.97

Chg

0.6000

Avg Vol

649422

Mkt Cap

3817344643

Exch

NYSE

Country

US

Phone

781 848 7100

DCF Diff

-180.6085

DCF

271.6685

Div Yield

0.0000

P/S

2.8618

EV Multiple

17.0925

P/FV

4.1970

Div Yield %

0.0000

P/E

33.0740

PEG

4.1550

Payout

0.0000

Current Ratio

3.7627

Quick Ratio

2.3254

Cash Ratio

1.3243

DSO

55.1333

DIO

210.8364

Op Cycle

265.9697

DPO

43.3922

CCC

222.5775

Gross Margin

0.5149

Op Margin

0.1326

Pretax Margin

0.1102

Net Margin

0.0861

Eff Tax Rate

0.2184

ROA

0.0452

ROE

0.1241

ROCE

0.0775

NI/EBT

0.7816

EBT/EBIT

0.8313

EBIT/Rev

0.1326

Debt Ratio

0.4815

D/E

1.3515

LT Debt/Cap

0.5737

Total Debt/Cap

0.5747

Int Coverage

9.8751

CF/Debt

0.1105

Equity Multi

2.8066

Rec Turnover

6.6203

Pay Turnover

8.4117

Inv Turnover

1.7312

FA Turnover

4.4099

Asset Turnover

0.5250

OCF/Share

2.6548

FCF/Share

1.4321

Cash/Share

6.7932

OCF/Sales

0.1014

FCF/OCF

0.5394

CF Coverage

0.1105

ST Coverage

26.4717

CapEx Coverage

2.1712

Div&CapEx Cov

2.1712

P/BV

4.1970

P/B

4.1970

P/S

2.8618

P/E

33.0740

P/FCF

52.3246

P/OCF

28.0962

P/CF

28.0962

PEG

4.1550

P/S

2.8618

EV Multiple

17.0925

P/FV

4.1970

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Jul 24, 14:31 Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View - Zacks Investment Research Zacks Investment Research May 28, 22:53 3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List Zacks Investment Research Dec 28, 13:13 Here's Why You Should Invest in Insulet (PODD) Stock for Now Zacks Investment Research Dec 26, 11:26 5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024 Zacks Investment Research Dec 25, 09:30 Haemonetics (HAE) Just Reclaimed the 200-Day Moving Average Zacks Investment Research Dec 25, 09:30 Haemonetics (HAE) Just Overtook the 50-Day Moving Average Zacks Investment Research Nov 24, 12:28 Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut

Revenue Product Segmentation